SAN ANTONIO (Dec. 1, 2011) — In a free Dec. 8 public lecture, Ian M. Thompson Jr., M.D., will discuss the latest information in prostate cancer prevention and treatment. Updating a popular presentation he first gave last year, Dr. Thompson, director of the Cancer Therapy & Research Center at the UT Health Science Center, will discuss what PSA results reveal about your risk for prostate cancer – and what they cannot tell you.
PSA tests have increased our ability to detect prostate cancer in men, but Dr. Thompson’s nationally recognized research has shown that patients and physicians must go beyond PSA and use other measures to evaluate risk. Dr. Thompson will talk about how to put PSA results in perspective along with age and other risk factors.
“This presentation is essential for men trying to understand the recent national recommendations regarding PSA that they saw in the newspaper and on TV in the last few weeks,” said Dr. Thompson.
The talk runs from 6 to 7:30 p.m. on the fourth floor of the Grossman Building at the Cancer Therapy & Research Center, 7979 Wurzbach Road.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.